March 29, 2018 / 1:27 AM / a year ago

Federal Circuit halts PTAB review of Allergan patents owned by tribe

A U.S. appeals court on Wednesday instructed a U.S. patent tribunal to hold off on deciding the validity of patents covering Allergan PLC’s drug Restasis, saying it first wanted to consider the novel jurisdictional issues raised by Allergan assigning the patents to a Native American tribe.

The U.S. Court of Appeals for the Federal Circuit granted a request by the Saint Regis Mohawk Tribe for a temporary stay that blocks the Patent Trial and Appeal Board from ruling on the validity of the patents on Restasis, a dry eye treatment that generates more than $1 billion a year in revenue.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below